8-K/A: WTW Reports Strong Q3 2025 Earnings with Margin Expansion

Willis Towers Watson reported solid third-quarter 2025 financial results, driven by 5% organic revenue growth, significant adjusted operating margin expansion, and an 11% increase in adjusted diluted earnings per share.

Summary

• Revenue for Q3 2025 was $2.288 billion, flat compared to the prior-year quarter due to the sale of TRANZACT.
• Organic Revenue grew by 5% for the quarter.
• Diluted Earnings per Share was $3.11 for Q3 2025, a significant improvement from a loss of $(16.44) in Q3 2024.
• Adjusted Diluted Earnings per Share increased by 11% to $3.07 for Q3 2025, up from $2.77 in Q3 2024.
• Operating Margin was 18.3% for Q3 2025, compared to (33.5)% in Q3 2024.
• Adjusted Operating Margin expanded by 230 basis points to 20.4% for Q3 2025, from 18.1% in Q3 2024.
• Net Income for Q3 2025 was $306 million, a substantial recovery from a Net Loss of $1.67 billion in Q3 2024.
• Adjusted EBITDA increased by 8% to $515 million, or 22.5% of revenue, compared to $479 million, or 20.9% of revenue, in Q3 2024.
• Cash flows from operating activities for the nine months ended September 30, 2025, were $1.0 billion, up from $913 million in the prior-year period.
• Free cash flow for the nine months ended September 30, 2025, was $838 million, an increase of $114 million from $724 million in the prior-year period.
• The Company repurchased 1,848,098 of its outstanding shares for $600 million during Q3 2025.
• The Health, Wealth & Career (HWC) segment reported organic revenue growth of 4% and an operating margin of 28.6%, up 390 basis points.
• The Risk & Broking (R&B) segment reported organic revenue growth of 6% and an operating margin of 18.8%, up 70 basis points.

Sentiment

Score: 8

Explanation: The company delivered strong adjusted financial results with significant margin expansion and EPS growth, alongside robust cash flow generation. The organic revenue growth across key segments is positive, and management expresses confidence in achieving full-year goals. While reported revenue was flat due to a divestiture, the underlying performance is strong. The outlook includes continued margin expansion and substantial share repurchases, indicating a positive trajectory.

Positives

• Strong 5% organic revenue growth demonstrates underlying business strength.
• Adjusted Diluted EPS increased by 11% to $3.07, indicating improved profitability.
• Adjusted Operating Margin expanded by 230 basis points to 20.4%, reflecting enhanced operating efficiencies.
• Net Income significantly recovered to $306 million from a substantial loss in the prior year, largely due to the absence of TRANZACT-related impairment charges.
• Adjusted EBITDA grew by 8% to $515 million, with margin expansion to 22.5% of revenue.
• Cash flows from operating activities increased to $1.0 billion for the nine-month period.
• Free cash flow rose by $114 million to $838 million, driven by operating margin expansion and reduced Transformation program outflows.
• HWC segment achieved 4% organic revenue growth and a 390 basis point increase in operating margin to 28.6%, primarily due to the TRANZACT sale and increased operating efficiencies.
• R&B segment delivered 6% organic revenue growth and a 70 basis point increase in operating margin to 18.8%, benefiting from operating leverage and Transformation program savings.
• The company repurchased $600 million of shares in the quarter, signaling confidence and returning capital to shareholders.

Negatives

• Reported revenue was flat year-over-year at $2.288 billion, primarily due to the sale of TRANZACT.
• HWC segment's reported revenue decreased by 5% (6% constant currency) due to the TRANZACT sale.
• Insurance Consulting and Technology (ICT) revenue within R&B was flat, as clients managed spend cautiously amid economic uncertainty.
• A change in compensation survey delivery patterns moved some Career segment revenue from Q3 to Q4.

Risks

• Ability to successfully establish, execute, and achieve global business strategy as it evolves.
• Ability to fully realize anticipated benefits of growth strategy, including inorganic growth through acquisitions.
• Ability to achieve short-term and long-term financial goals, such as with respect to cash flow generation.
• Changes in general economic conditions, business and political conditions, financial markets, inflation, credit availability, increased interest rates, trade policies, tariffs, and retaliatory actions.
• Adverse impacts of macroeconomic trends, including war (e.g., Russia-Ukraine), international disputes, terrorism, natural disasters, public health issues, and recessionary trends.
• Ability to successfully hedge against fluctuations in foreign currency rates.
• Material interruptions to or loss of information processing capabilities, or failure to effectively maintain and upgrade IT resources and systems, including cybersecurity breaches.
• Ability to comply with complex and evolving regulations related to data privacy, cybersecurity, and artificial intelligence.
• Risks relating to transitional arrangements subsequent to the completed sale of TRANZACT.
• Significant competition and potential for loss of market share and/or profitability.
• Impact of seasonality and differences in timing of renewals and non-recurring revenue.
• Insufficiency of client data protection, potential breaches of information systems, or insufficient safeguards against cybersecurity incidents.
• Risk of increased liability or new legal claims arising from new and existing products and services, and outcomes relating to outstanding litigation.
• Changes in the regulatory environment, including competition law and regulatory investigations.
• Ability to make divestitures or acquisitions, and to integrate or manage acquired/disposed businesses.
• Ability to successfully manage ongoing organizational changes, including from the multi-year operational transformation program.
• Ability to successfully enhance billing, collection, and other working capital efforts to increase free cash flow.
• Ability to properly identify and manage conflicts of interest.
• Reputational damage, including from association with third parties.
• Reliance on third-party service providers and suppliers.
• Risks relating to changes in management structures and senior leadership, and the loss of key employees.
• Risks of doing business internationally, including global trade policies, foreign currency exchange rates, and sanctions.
• Ability to effectively apply technology, data, and analytics solutions, including AI.
• Changes and developments in the insurance industry or the U.S. healthcare system.
• Inability to protect intellectual property rights, or potential infringement upon the intellectual property rights of others.
• Fluctuations in pension assets and liabilities and related changes in pension income.
• Capital structure, indebtedness amounts, limitations imposed by covenants, and maintenance of financial controls.
• Ability to obtain financing on favorable terms or at all, and adverse changes in credit ratings.
• Impact of recent or potential changes to U.S. or foreign laws, and enactment of additional regulations, including those impacting tax rates.
• U.S. federal income tax consequences to U.S. persons owning at least 10% of shares.
• Changes in accounting principles, estimates, or assumptions.
• Recognition of future impairment charges.
• Risks relating to or arising from environmental, social, and governance (ESG) practices.
• Fluctuation in revenue against relatively fixed or higher-than-expected expenses.
• Risk that investment levels across the portfolio increase, amplifying market downturns.
• Laws of Ireland being different from U.S. laws, potentially affording less protection to security holders.
• Holding company structure potentially preventing receipt of dividends or distributions from subsidiaries.

Future Outlook

The company expects to reach its full-year financial goals despite macro uncertainty. For 2025, a reinsurance joint venture with Bain Capital is expected to be a net headwind of approximately $0.10 per share on adjusted diluted EPS. Cash outflows are anticipated from accrued Transformation program costs. Share repurchases of approximately $1.5 billion are expected, subject to market conditions and investment opportunities. A foreign currency tailwind of approximately $0.15 on adjusted diluted EPS is expected in Q4 2025, and approximately $0.10 for the full year 2025. The company anticipates approximately 100 basis points of average annual adjusted operating margin expansion over the next three years in the Risk & Broking segment, with incremental annual margin expansion at Health, Wealth & Career and enterprise levels.

Management Comments

• "WTW's market-leading solutions and focused execution on our strategy drove another quarter of strong results."
• "In the third quarter, we delivered a solid revenue performance, alongside strong operating margin expansion and earnings per share growth."
• "As we enter the fourth quarter, our sustained momentum and continued traction in the market give us confidence in our ability to reach our full year financial goals, despite macro uncertainty."
• "I'd like to thank our colleagues for their hard work, commitment to our clients and support of one another."

Industry Context

WTW's strong organic revenue growth and margin expansion in Q3 2025 suggest resilience and effective strategy execution within the global advisory, broking, and solutions industry. The flat reported revenue due to the TRANZACT divestiture indicates a strategic portfolio shift, while the underlying organic growth across segments like Health, Wealth & Career and Risk & Broking points to robust demand for its core services. The cautious client spending in Insurance Consulting and Technology reflects broader economic uncertainties impacting discretionary corporate expenditures, a trend observed across various professional services sectors. The company's focus on operating efficiencies and share repurchases aligns with a mature industry player aiming to optimize shareholder value amidst a dynamic market.

Comparison to Industry Standards

• NA

Legal Proceedings

• A provision related to potential litigation arising out of a structured insurance program originally placed for a client over 15 years ago. This matter is considered highly bespoke and unlikely to be replicated, and while not believed to be material, it is excluded from adjusted results for comparability.

Stakeholder Impact

• Shareholders: Benefited from increased adjusted EPS, strong free cash flow, and significant share repurchases, indicating value creation and capital return.
• Employees: Management thanked colleagues for their hard work and commitment, suggesting a positive internal culture despite ongoing operational transformation efforts.
• Customers: The company's market-leading solutions and focused execution aim to enhance client service and satisfaction, driving organic revenue growth.
• Creditors: Improved operating performance and cash flow generation strengthen the company's financial health, potentially enhancing creditworthiness.

Next Steps

• Host a conference call on October 30, 2025, to discuss Q3 2025 financial results.
• Continue with expected share repurchases of approximately $1.5 billion in 2025, subject to market conditions and investment opportunities.
• Focus on achieving approximately 100 basis points of average annual adjusted operating margin expansion in R&B over the next three years.
• Pursue incremental annual margin expansion at HWC and enterprise levels.

Key Dates

Recommendation

The filing demonstrates robust underlying business performance with strong organic revenue growth, significant adjusted operating margin expansion, and double-digit adjusted EPS growth. The substantial increase in free cash flow and the commitment to $1.5 billion in share repurchases signal strong financial health and a proactive approach to shareholder returns. Despite the flat reported revenue due to the TRANZACT divestiture, the core business is performing exceptionally well, and management's confident outlook for achieving full-year goals, coupled with anticipated multi-year margin expansion, makes this an attractive investment opportunity.

Keywords

WTW, Willis Towers Watson, Q3 2025 Earnings, Financial Results, Organic Revenue Growth, Adjusted EPS, Operating Margin, EBITDA, Cash Flow, Share Repurchase, Health Wealth & Career, Risk & Broking, Insurance Brokerage, Consulting, Advisory, SEC Filing, 8-K/A